N
Centralnervesystemet
Parkinsonisme
Antiparkinsonmidler
Levodopa kombineret med decarboxylasehæmmer
MAO-B-hæmmere
COMT-hæmmere
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
Dopaminagonister
Antikolinerge midler
Amantadin
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
N04BA
Revideret: 27.05.2020
Karen Østergaard (Forfatter),
Dansk Neurologisk Selskab
Tove Henriksen (Referent),
Dansk Selskab for Bevægeforstyrrelser
Indledning | Anvendelsesområder | Behandlingsvejledning | Præparatvalg | Doseringsforslag | Nedsat lever- og/eller nyrefunktion | Kontraindikationer | Forsigtighedsregler | Patientsikkerhed | Bivirkninger | Interaktioner | Graviditet | Amning | Forgiftning | Farmakodynamik | Farmakokinetik | Tilskud | Præparater | Referencer
Der henvises i øvrigt også til Levodopa kombineret med decarboxylasehæmmer og COMT-hæmmere for en oversigt over præparater med indholdsstofferne hver for sig.
For yderligere oplysninger om behandling af parkinsonisme, se antiparkinsonmidler.
Præparater
| Indholdsstof | Navn og firma | Dispform og styrke | Pakning | Pris DDD |
|---|---|---|---|---|
| Carbidopa Entacapon Levodopa |
Lecigon® Nordic Infucare
|
enteralgel 20+5+20 mg/ml | 7 x 47 ml | 550,02 |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 75+18,75+200 mg | 150 stk. | |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 125+31,25+200 mg | 150 stk. | 34,52 |
| Carbidopa Entacapon Levodopa |
Levocaren Parallelimport
|
filmovertrukne tabletter 175+43,75+200 mg | 150 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | 15,44 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 130 stk. | 31,05 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 10,69 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 53,02 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 24,85 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 42,02 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk | 12,23 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 34,58 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk | 8,49 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 6,47 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 15,47 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 130 stk. | 27,53 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 100 stk | 12,19 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
03.05.2021
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
03.05.2021
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
03.05.2021
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
03.05.2021
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
03.05.2021
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 20,13 |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 41,93 |
| Carbidopa Entacapon Levodopa |
Pentiro Stada
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 6,44 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 30 Stk. | |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 30 stk. | 60,83 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 59,57 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Orifarm) | 24,66 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Paranova) | 38,52 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (2care4) | 38,10 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 48,77 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | 39,71 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 32,51 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 30 stk. | 30,67 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 27,28 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 58,01 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 130 stk. | 20,69 |
Referencer
1563. Stocchi F, Rascol O, Kieburtz K et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010; 68:18-27, http://www.ncbi.nlm.nih.gov/pubmed/20582993 (Lokaliseret 24. maj 2016)
4678. Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back?. Ann Neurol. 2010; 68:3-5, https://www.ncbi.nlm.nih.gov/pubmed/20583222 (Lokaliseret 12. august 2019)
